Molnupiravir

Molnupiravir, a SARS-CoV-2 antiviral drug, is mutagenic in cells

Molnupiravir might be the first highly effective antiviral drug given emergency use authorization for treatment of COVID-19. Should we be concerned about the results of a recent study which show that the drug is mutagenic in cells? Molnupiravir is an orally available pro-drug of the nucleoside analog N4-hydroxycytidine (NHC). The latter is a nucleoside analogue …

Molnupiravir, a SARS-CoV-2 antiviral drug, is mutagenic in cells Read More »

Scroll to Top